Pharmaceutical Pricing in Europe : Is Differential Pricing a Win-Win Solution?
Year of publication: |
2015
|
---|---|
Authors: | Garau, Martina |
Other Persons: | Towse, Adrian (contributor) ; Danzon, Patricia M. (contributor) |
Publisher: |
[2015]: [S.l.] : SSRN |
Subject: | EU-Staaten | EU countries | Arzneimittel | Pharmaceuticals | Preisdifferenzierung | Price discrimination | Europa | Europe | Preis | Price | Preismanagement | Pricing strategy | Pharmaindustrie | Pharmaceutical industry | Preisregulierung | Price regulation | Arzneimittelmarkt | Pharmaceutical market |
Extent: | 1 Online-Ressource (7 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments February 1, 2011 erstellt |
Other identifiers: | 10.2139/ssrn.2639694 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
European pharmaceutical prices, 1964-74
Cooper, Michael H., (1975)
-
Vogler, Sabine, (2019)
-
European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending
Golec, Joseph H., (2006)
- More ...
-
Using QALYs in Cancer: A Review of the Methodological Limitations
Garau, Martina, (2011)
-
Using QALYs in Cancer : A Review of the Methdological Limitations
Garau, Martina, (2015)
-
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
Garau, Martina, (2015)
- More ...